Summit Therapeutics is upgraded to Buy as sentiment bottoms and ivonescimab catalysts near; assess upside vs. cash burn.
Think about a time when our heart pounded with a sudden sense of dread, breathing quickened and muscles tensed, as if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results